Edwards Historical Financial Ratios
EW Stock | USD 86.65 0.59 0.68% |
Edwards Lifesciences is recently reporting on over 114 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.82 will help investors to properly organize and evaluate Edwards Lifesciences Corp financial condition quickly.
Edwards |
About Edwards Financial Ratios Analysis
Edwards Lifesciences CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Edwards Lifesciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Edwards financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Edwards Lifesciences history.
Edwards Lifesciences Financial Ratios Chart
Edwards Lifesciences Corp financial ratios usually calculated using numerical values taken directly from Edwards Lifesciences financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Edwards Lifesciences. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At this time, Edwards Lifesciences' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 77.16 in 2024, whereas Dividend Yield is likely to drop 0 in 2024. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Edwards Lifesciences Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Edwards Lifesciences sales, a figure that is much harder to manipulate than other Edwards Lifesciences Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Edwards Lifesciences Corp dividend as a percentage of Edwards Lifesciences stock price. Edwards Lifesciences Corp dividend yield is a measure of Edwards Lifesciences stock productivity, which can be interpreted as interest rate earned on an Edwards Lifesciences investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Edwards Lifesciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. At this time, Edwards Lifesciences' POCF Ratio is fairly stable compared to the past year. PFCF Ratio is likely to climb to 77.16 in 2024, whereas Dividend Yield is likely to drop 0 in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.001964 | 0.00317 | 0.003673 | 0.003489 | Price To Sales Ratio | 15.43 | 8.58 | 7.7 | 4.36 |
Edwards Lifesciences fundamentals Correlations
Click cells to compare fundamentals
Edwards Lifesciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Edwards Lifesciences fundamentals Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Price To Sales Ratio | 11.18 | 12.95 | 15.43 | 8.58 | 7.7 | 4.36 | |
Dividend Yield | 3.89E-4 | 0.002474 | 0.001964 | 0.00317 | 0.003673 | 0.003489 | |
Ptb Ratio | 11.71 | 12.42 | 13.84 | 7.95 | 6.96 | 4.82 | |
Days Sales Outstanding | 50.29 | 50.16 | 46.38 | 47.41 | 50.87 | 60.3 | |
Book Value Per Share | 6.64 | 7.35 | 9.36 | 9.38 | 10.96 | 11.51 | |
Free Cash Flow Yield | 0.0185 | 0.0114 | 0.0174 | 0.0206 | 0.0136 | 0.0129 | |
Invested Capital | 0.19 | 0.16 | 0.15 | 0.12 | 0.1 | 0.0993 | |
Operating Cash Flow Per Share | 1.48 | 1.89 | 1.69 | 2.78 | 1.97 | 1.55 | |
Stock Based Compensation To Revenue | 0.0179 | 0.0191 | 0.0187 | 0.0211 | 0.0236 | 0.0293 | |
Pb Ratio | 11.71 | 12.42 | 13.84 | 7.95 | 6.96 | 4.82 | |
Ev To Sales | 8.57 | 11.06 | 12.84 | 15.4 | 7.63 | 4.39 | |
Free Cash Flow Per Share | 1.3 | 1.09 | 1.44 | 1.04 | 2.25 | 1.54 | |
Inventory Turnover | 1.74 | 1.35 | 1.72 | 1.23 | 1.18 | 1.12 | |
Net Income Per Share | 1.68 | 1.32 | 2.41 | 2.46 | 2.31 | 2.43 | |
Days Of Inventory On Hand | 209.91 | 271.0 | 212.38 | 295.78 | 309.03 | 324.48 | |
Payables Turnover | 6.18 | 5.5 | 6.11 | 5.35 | 6.85 | 4.78 | |
Capex To Revenue | (0.064) | (0.0929) | (0.063) | (0.0492) | (0.0443) | (0.0466) | |
Pocfratio | 41.2 | 53.87 | 46.62 | 37.91 | 51.64 | 54.22 | |
Interest Coverage | 55.4 | 103.06 | 73.29 | 91.07 | 87.16 | 46.38 | |
Pfcf Ratio | 53.93 | 87.79 | 57.58 | 48.44 | 73.49 | 77.16 | |
Days Payables Outstanding | 59.09 | 66.37 | 59.77 | 68.21 | 53.28 | 95.13 | |
Ev To Operating Cash Flow | 40.78 | 53.41 | 46.52 | 37.85 | 51.14 | 53.7 | |
Pe Ratio | 46.42 | 68.98 | 53.72 | 30.35 | 32.99 | 31.34 | |
Ev To Free Cash Flow | 53.38 | 87.03 | 57.46 | 48.36 | 72.77 | 76.41 | |
Earnings Yield | 0.0215 | 0.0145 | 0.0186 | 0.033 | 0.0303 | 0.0169 | |
Net Debt To E B I T D A | (0.0865) | (0.38) | (0.28) | (0.0425) | (0.23) | (0.22) | |
Current Ratio | 3.31 | 3.46 | 3.08 | 3.03 | 3.38 | 2.33 | |
Tangible Book Value Per Share | 4.23 | 4.93 | 6.97 | 7.04 | 8.3 | 8.72 | |
Receivables Turnover | 7.26 | 7.28 | 7.87 | 7.7 | 7.18 | 5.45 |
Pair Trading with Edwards Lifesciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Edwards Stock
0.81 | ELMD | Electromed | PairCorr |
0.76 | FEMY | Femasys Financial Report 9th of May 2024 | PairCorr |
Moving against Edwards Stock
0.9 | IVP | Inspire Veterinary | PairCorr |
0.76 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
0.68 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
0.53 | DYNT | Dynatronics Financial Report 9th of May 2024 | PairCorr |
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Edwards Stock analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.3 | Revenue Per Share 9.897 | Quarterly Revenue Growth 0.138 | Return On Assets 0.1225 |
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.